Literature DB >> 7508734

Two types of prostacyclin receptor coupling to stimulation of adenylate cyclase and phosphatidylinositol hydrolysis in a cultured mast cell line, BNu-2cl3 cells.

M Oka1, M Negishi, N Nishigaki, A Ichikawa.   

Abstract

Prostacyclin (PGI2)-mediated signal transduction was examined in interleukin 3 (IL-3)-dependent BNu-2cl3 mast cells. Iloprost, a stable PGI2 analogue, induced the accumulation of intracellular cAMP and IP3, and an increase in the intracellular Ca2+ concentration. Pretreatment of the cells with a protein kinase C activator, 12-O-tetradecanoyl phorbol 13-acetate, suppressed the iloprost-induced IP3 accumulation and Ca2+ mobilization, but inversely potentiated the cAMP accumulation, suggesting that neither of these signal transduction pathways of iloprosts is the result of a secondary effect of activation of the other. Removal of IL-3 from the culture medium reduced the iloprost-induced IP3 accumulation and Ca2+ mobilization, while it had no effect on the iloprost-induced cAMP accumulation at all. These results taken together suggest that BNu-2cl3 cells express two types of PGI2 receptor; one couples to stimulation of adenylate cyclase, its expression being independent of IL-3, while the other couples to phosphatidylinositol hydrolysis, its expression being dependent on IL-3.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7508734     DOI: 10.1016/0898-6568(93)90059-u

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  2 in total

1.  Prostacyclin receptor-independent inhibition of phospholipase C activity by non-prostanoid prostacyclin mimetics.

Authors:  K B Chow; Y H Wong; H Wise
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

2.  Characterization of prostanoid receptors mediating inhibition of histamine release from anti-IgE-activated rat peritoneal mast cells.

Authors:  C L Chan; R L Jones; H Y Lau
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.